immatics biotechnologies GmbH
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $50,559 | $18,755 | $30,447 | $15,921 |
Gross Profit | 50,559 | 18,660 | -1,660 | -17,346 |
EBITDA | 915 | -14,524 | -10,528 | -24,135 |
EBIT | -2,118 | -17,626 | -13,560 | -25,890 |
Net Income | -8,570 | -18,022 | -3,071 | -26,148 |
Net Change In Cash | 50,559 | 18,755 | 30,447 | 15,921 |
Free Cash Flow | -36,530 | -35,989 | -42,026 | 69,784 |
Cash | 189,199 | 158,143 | 122,206 | 218,472 |
Basic Shares | 106,011 | 98,740 | 84,657 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $53,997 | $172,831 | $34,763 | $31,253 |
Gross Profit | -64,666 | 66,052 | -52,811 | -35,831 |
EBITDA | -88,929 | 50,041 | -83,560 | -64,441 |
EBIT | -96,163 | 43,199 | -89,029 | -68,562 |
Net Income | -96,994 | 37,514 | -95,061 | -229,348 |
Net Change In Cash | 53,997 | 172,831 | 34,763 | 31,253 |
Free Cash Flow | -12,729 | 93,916 | -87,441 | -93,134 |
Cash | 218,472 | 148,519 | 132,994 | 207,530 |
Basic Shares | 80,546 | 68,824 | 62,912 | 48,001 |
